摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[1-(3,3-Dimethyl-butyl)-4-oxo-3,4-dihydro-phthalazin-6-yl]-3-(3-trifluoromethyl-phenyl)-urea | 497255-46-6

中文名称
——
中文别名
——
英文名称
1-[1-(3,3-Dimethyl-butyl)-4-oxo-3,4-dihydro-phthalazin-6-yl]-3-(3-trifluoromethyl-phenyl)-urea
英文别名
1-[1-(3,3-dimethylbutyl)-4-oxo-3H-phthalazin-6-yl]-3-[3-(trifluoromethyl)phenyl]urea
1-[1-(3,3-Dimethyl-butyl)-4-oxo-3,4-dihydro-phthalazin-6-yl]-3-(3-trifluoromethyl-phenyl)-urea化学式
CAS
497255-46-6
化学式
C22H23F3N4O2
mdl
——
分子量
432.445
InChiKey
KFUYJVMFONEXBQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.30±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.5
  • 重原子数:
    31
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.32
  • 拓扑面积:
    82.6
  • 氢给体数:
    3
  • 氢受体数:
    6

文献信息

  • 4-amino-thieno[3,2-c] pyridine-7-carboxylic acid derivatives
    申请人:Bartkovitz Joseph David
    公开号:US20070060607A1
    公开(公告)日:2007-03-15
    The present invention relates to compounds of the formula medicaments containing them and the use of these compounds as pharmaceutically active agents. The compounds exhibit activity as Raf kinase inhibitors and therefore may be useful for the treatment of diseases mediated by said kinases, especially as anticancer agents.
    本发明涉及公式化合物、含有它们的药物以及将这些化合物用作药用活性剂的用途。这些化合物表现出作为Raf激酶抑制剂的活性,因此可能对通过该激酶介导的疾病的治疗有用,特别是作为抗癌剂。
  • Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
    申请人:PHARMACIA & UPJOHN S.p.A.
    公开号:US20030073692A1
    公开(公告)日:2003-04-17
    Compounds which are amino-phthalazinone derivatives and pharmaceutically acceptable salts thereof, together with pharmaceutical compositions comprising them are disclosed; these compounds or compositions are useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders.
    本文揭示了一种基-邻苯二氮酮生物及其药学上可接受的盐,以及包含它们的制药组合物;这些化合物或组合物在治疗由于和/或与蛋白激酶活性改变有关的疾病方面具有用处,例如癌症、细胞增殖性疾病、阿尔茨海默病、病毒感染、自身免疫性疾病和神经退行性疾病。
  • AMINO-PHTHALAZINONE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
    申请人:Pharmacia Italia S.p.A.
    公开号:EP1427708A1
    公开(公告)日:2004-06-16
  • AMINO-PHTHALAZINONE DERIVATIVES AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
    申请人:Pfizer Italia S.r.l.
    公开号:EP1427708B1
    公开(公告)日:2008-09-10
  • 4-AMINO-THIENO[3,2-C]PYRIDINE-7-CARBOXYLIC ACID DERIVATIVES
    申请人:F.HOFFMANN-LA ROCHE AG
    公开号:EP1926737A1
    公开(公告)日:2008-06-04
查看更多